• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】17000

【品名】5-bromo-9-oxatricyclo[6.2.2.0(2,7)]dodeca-2,4,6-trien-10-one

【CA登记号】

【 分 子 式 】C11H9BrO2

【 分 子 量 】253.09526

【元素组成】C 52.2% H 3.58% Br 31.57% O 12.64%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(XIX)

Tritium-labeled RS-25259-197 can be obtained by the reaction of methyl 4-bromophenylacetate (XI) with methyl chloroformate (XII) by means of lithium diisopropylamide (LDA) in THF, giving the malonic ester (XIII), which is condensed with methyl acrylate (XIV) by means of Na in methanol to yield the tricarboxylic ester (XV). The decarboxylative hydrolysis of (XV) first with NaOH and finally in acidic medium (HCl) affords 2-(4-bromophenyl)glutaric acid (XVI), which is cyclized with hot polyphosphoric acid (PPA) to give 6-bromo-4-oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (XVII). The reduction of (XVII) with NaBH4 in isopropanol yields the corresponding hydroxy acid (XVIII), which is dehydrated with p-toluenesulfonic acid to the lactone (XIX). Isomerization of (XIX) with H3PO4 in THF affords 6-bromo-1,2-dihydronaphthalene-1-carboxylic acid (XX), which is condensed with quinuclidin-3(S)-ylamine (III) by means of dicyclohexylcarbodiimide (DCC) and hydroxybenzotriazole (HOBT) in acetonitrile to give the corresponding amide as a mixture of diastereomers that is resolved by chromatography and crystallization in order to obtain the (S,S)-isomer (XXI). The hydrogenation of (XXI) with tritium (3H2) and Pd/C in ethyl acetate affords (S,S)-N-(3-quinuclidinyl)-3,4,7-tri-3H-1,2,3,4-tetrahydronaphthalene-1-carboxamide (XXII), which is reduced with the complex borane.dimethylsulfide to the corresponding amine (XXIII). Finally, this compound is cyclized with trichloromethyl chloroformate (diphosgene) in refluxing toluene.

1 Graul, A.; Castañer, J.; RS-25259-197. Drugs Fut 1996, 21, 9, 906.
2 Gong, L.; Parnes, H.; Synthesis of the 3H-labelled 5-HT3 antagonist (RS-25259-197) at high specific activity. J Label Compd Radiopharm 1996, 38, 5, 425.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(III) 16984 (3S)-1-azabicyclo[2.2.2]octan-3-amine; 1-aza-Bicyclo[2.2.2]oct-3-ylamine; (3S)-1-azabicyclo[2.2.2]oct-3-ylamine 120570-05-0 C7H14N2 详情 详情
(XI) 16992 methyl 2-(4-bromophenyl)acetate 41841-16-1 C9H9BrO2 详情 详情
(XII) 16993 methyl chlorocarbonate;Carbonochloridic acid methyl ester;[(chlorocarbonyl)oxy]methane;methyl chloroformate 79-22-1 C2H3ClO2 详情 详情
(XIII) 16994 dimethyl 2-(4-bromophenyl)malonate C11H11BrO4 详情 详情
(XIV) 14156 methyl acrylate 96-33-3 C4H6O2 详情 详情
(XV) 16996 trimethyl 1-(4-bromophenyl)-1,1,3-propanetricarboxylate C15H17BrO6 详情 详情
(XVI) 16997 2-(4-bromophenyl)pentanedioic acid C11H11BrO4 详情 详情
(XVII) 16998 6-bromo-4-oxo-1,2,3,4-tetrahydro-1-naphthalenecarboxylic acid C11H9BrO3 详情 详情
(XVIII) 16999 6-bromo-4-hydroxy-1,2,3,4-tetrahydro-1-naphthalenecarboxylic acid C11H11BrO3 详情 详情
(XIX) 17000 5-bromo-9-oxatricyclo[6.2.2.0(2,7)]dodeca-2,4,6-trien-10-one C11H9BrO2 详情 详情
(XX) 17001 6-bromo-1,2-dihydro-1-naphthalenecarboxylic acid C11H9BrO2 详情 详情
(XXI) 17002 (1S)-N-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-6-bromo-1,2-dihydro-1-naphthalenecarboxamide C18H21BrN2O 详情 详情
(XXII) 17003 (1S)-N-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-1,2,3,4-tetrahydro-1-naphthalenecarboxamide C18H24N2O 详情 详情
(XXII) 45319 (1S)-N-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-1,2,3,4-tetrahydro-1-naphthalenecarboxamide C18H24N2O 详情 详情
(XXIII) 17004 (3S)-N-[(1S)-1,2,3,4-tetrahydro-1-naphthalenylmethyl]-1-azabicyclo[2.2.2]octan-3-amine; N-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-N-[(1S)-1,2,3,4-tetrahydro-1-naphthalenylmethyl]amine C18H26N2 详情 详情
(XXIII) 45320 N-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-N-[(1S)-1,2,3,4-tetrahydro-1-naphthalenylmethyl]amine; (3S)-N-[(1S)-1,2,3,4-tetrahydro-1-naphthalenylmethyl]-1-azabicyclo[2.2.2]octan-3-amine C18H26N2 详情 详情
Extended Information